Catalyst Awards for the Development of Therapeutics, Diagnostics, Devices, and Digital Health

The Catalyst Program is UCSF’s translational accelerator focused on advancing UCSF discoveries with clinical impact and commercial potential. The centerpiece of the Catalyst Program are Catalyst Awards that provide both industry advisor mentorship and seed funding to UCSF PIs with promising projects. The Catalyst Awards are focused on the development of therapeutics, diagnostics, medical devices and digital health. Previous Catalyst Awardees include UCSF investigators whose works span a broad range of innovative concepts. The mentorship and funding awardees received enabled them to reach key milestones along the development path towards safe and effective solutions for patients.

Therapeutics Collaboration

ShangPharma Awards for the Development of Therapeutics

UCSF has a collaboration with ShangPharma Innovation to progress therapeutics projects towards the clinic. This collaboration, managed by the Catalyst Program, includes both direct project funding and contract research services provided by ChemPartner. 

Award Amounts
Therapeutics - if chosen for a collaboration with ShangPharma Innovation, a project can qualify for funding of up to ~$400K/year together plus up to ~$600K/year in CRO services  at ChemPartner. If chosen for UCSF Catalyst Award funding the maximum award is $100K

Diagnostics - up to $100K
Medical Devices - up to $100K
Digital Health - up to $50K 

See RAP website for full details!

Monday, September 23, 2019 to 2:00pm

Event Type



Clinical & Translational Science Institute (CTSI)
Contact Info


Recent Activity